Clinical Trial

Re-Entry XR-NTX for Rural Women with Opioid Use Disorder

Study Description

Re-entry XR-NTX for Rural Women With Opioid Use Disorder

The overall aim of this R34 proposal is to examine the feasibility, acceptability, and short-term outcomes associated with an innovative service delivery model to increase adherence to extended-release naltrexone (XR-NTX) during the transition from jail to the community for rural women with opioid use disorder (OUD). The significance of this study is grounded in the public health emergency associated with the opioid epidemic in rural Appalachia, the increased vulnerability of rural women with OUD, and the dearth of available and accessible evidence-based treatment in the region. This study has potential to make a significant contribution to the OUD treatment field by advancing knowledge on innovative service delivery models to increase access to evidence-based treatment to reduce the prevalence of opioid use disorders and related health disparities among hard-to-reach, high-risk, underserved populations.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - XR-NTX community location

XR-NTX will be administered in both conditions, but the location of on-going injections will vary

Additional Information

Official Study Title

Re-entry XR-NTX for Rural Women With Opioid Use Disorder

Clinical Trial ID

NCT03447743

ParticipAid ID

xe7gOe